These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20876437)

  • 1. Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community.
    Cheng S; Lyass A; Massaro JM; O'Connor GT; Keaney JF; Vasan RS
    Circulation; 2010 Oct; 122(15):1470-7. PubMed ID: 20876437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Exhaled Carbon Monoxide With Stroke Incidence and Subclinical Vascular Brain Injury: Framingham Heart Study.
    Nayor M; Enserro DM; Beiser AS; Cheng S; DeCarli C; Vasan RS; Seshadri S
    Stroke; 2016 Feb; 47(2):383-9. PubMed ID: 26696648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of exhaled carbon monoxide with risk of cardio-cerebral-vascular disease in the China Kadoorie Biobank cohort study.
    Qiu G; Yu K; Yu C; Li W; Lv J; Guo Y; Bian Z; Yang L; Chen Y; Chen Z; Hu FB; Li L; Wu T
    Sci Rep; 2020 Nov; 10(1):19507. PubMed ID: 33177548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes.
    Cheng S; Enserro D; Xanthakis V; Sullivan LM; Murabito JM; Benjamin EJ; Polak JF; O'Donnell CJ; Wolf PA; O'Connor GT; Keaney JF; Vasan RS
    Eur Heart J; 2014 Nov; 35(42):2980-7. PubMed ID: 24574370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Exhaled Carbon Monoxide With Ideal Cardiovascular Health, Circulating Biomarkers, and Incidence of Heart Failure in the Framingham Offspring Study.
    Tun B; Ehrbar R; Short M; Cheng S; Vasan RS; Xanthakis V
    J Am Heart Assoc; 2020 Nov; 9(21):e016762. PubMed ID: 33100134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between obstructive sleep apnea and endogenous carbon monoxide.
    Azuma M; Murase K; Tachikawa R; Hamada S; Matsumoto T; Minami T; Inouchi M; Tanizawa K; Handa T; Oga T; Mishima M; Chin K
    J Appl Physiol (1985); 2017 Jan; 122(1):104-111. PubMed ID: 27856716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled carbon monoxide level and smoking status in urban Khon Kaen adults.
    Chatrchaiwiwatana S; Ratanasiri A
    J Med Assoc Thai; 2008 Nov; 91(11):1669-76. PubMed ID: 19127787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Exhaled Carbon Monoxide and Fractional Exhaled Nitric Oxide with Metabolic Syndrome: A Cohort Study.
    Guo Y; Ma J; Lu W; He J; Zhang R; Yuan J; Chen W
    Sci Rep; 2016 Apr; 6():24532. PubMed ID: 27076211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of exhaled carbon monoxide measured during an intervention program predict 1-year smoking cessation: a retrospective observational cohort study.
    Shie HG; Pan SW; Yu WK; Chen WC; Ho LI; Ko HK
    NPJ Prim Care Respir Med; 2017 Oct; 27(1):59. PubMed ID: 29038512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of air pollution on exhaled carbon monoxide levels in smokers and non-smokers. A prospective cross-sectional study.
    Maga M; Janik MK; Wachsmann A; Chrząstek-Janik O; Koziej M; Bajkowski M; Maga P; Tyrak K; Wójcik K; Gregorczyk-Maga I; Niżankowski R
    Environ Res; 2017 Jan; 152():496-502. PubMed ID: 27712837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous carbon monoxide and cardiometabolic risk: can measuring exhaled carbon monoxide be used to refine cardiometabolic risk assessment?
    Nayor M; Vasan RS
    Future Cardiol; 2015; 11(1):9-12. PubMed ID: 25606696
    [No Abstract]   [Full Text] [Related]  

  • 12. Physical activity attenuates cardiovascular risk and mortality in men and women with and without the metabolic syndrome - a 20-year follow-up of a population-based cohort of 60-year-olds.
    Ekblom-Bak E; Halldin M; Vikström M; Stenling A; Gigante B; de Faire U; Leander K; Hellénius ML
    Eur J Prev Cardiol; 2021 Oct; 28(12):1376-1385. PubMed ID: 34647588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed heart rate variability: a dose-dependent response to elevated nitric oxide and carbon monoxide in exhaled breath.
    Qiu G; Feng Y; Li X; Deng H; Dai X; Deng Q; Huang S; He M; Guo H; Zhang X; Hu FB; Wu T
    Int J Cardiol; 2013 Oct; 168(6):e155-7. PubMed ID: 24041983
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Diabetes; 2005 Nov; 54(11):3252-7. PubMed ID: 16249452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visit-to-visit variability in the measurements of metabolic syndrome components and the risk of all-cause mortality, cardiovascular disease, and arterial stiffness.
    Wu M; Shu Y; Wang L; Song L; Chen S; Liu Y; Bi J; Li D; Yang Y; Hu Y; Sun Y; Wang Y; Wu S; Tian Y
    Nutr Metab Cardiovasc Dis; 2021 Sep; 31(10):2895-2903. PubMed ID: 34420814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors.
    Abraham TM; Pedley A; Massaro JM; Hoffmann U; Fox CS
    Circulation; 2015 Oct; 132(17):1639-47. PubMed ID: 26294660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled carbon monoxide levels correlate with incidence of oral mucosal lesions independent of smoking status.
    Gregorczyk-Maga I; Wachsmann A; Olszewska M; Partyka L
    Int J Environ Health Res; 2019 Jun; 29(3):290-300. PubMed ID: 30375883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study.
    Herder C; Kannenberg JM; Carstensen-Kirberg M; Huth C; Meisinger C; Koenig W; Peters A; Rathmann W; Roden M; Thorand B
    Cardiovasc Diabetol; 2017 Jan; 16(1):17. PubMed ID: 28143481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.